000859684 001__ 859684
000859684 005__ 20210130000350.0
000859684 0247_ $$2doi$$a10.1016/j.vascn.2018.11.005
000859684 0247_ $$2ISSN$$a1056-8719
000859684 0247_ $$2ISSN$$a1873-488X
000859684 0247_ $$2pmid$$apmid:30476620
000859684 0247_ $$2WOS$$aWOS:000454124000004
000859684 037__ $$aFZJ-2019-00523
000859684 082__ $$a610
000859684 1001_ $$0P:(DE-Juel1)156407$$aSchneider, Daniela$$b0$$eCorresponding author$$ufzj
000859684 245__ $$aInfluence of incubation conditions on microsomal metabolism of xanthine-derived A1 adenosine receptor ligands
000859684 260__ $$aNew York, NY [u.a.]$$bElsevier$$c2019
000859684 3367_ $$2DRIVER$$aarticle
000859684 3367_ $$2DataCite$$aOutput Types/Journal article
000859684 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1554817315_28299
000859684 3367_ $$2BibTeX$$aARTICLE
000859684 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000859684 3367_ $$00$$2EndNote$$aJournal Article
000859684 520__ $$aIntroduction:In vitro metabolism models such as liver microsomes represent an important tool for the development of novel radioligands.Comparability and physiological relevance of invitro metabolism data criticallydepend on the careful evaluation and optimization of assay protocols. We therefore investigated the influence ofincubation conditions on the microsomal stability of xanthine-derived A1 adenosine receptor (A 1AR) ligandswhich have been developed for positron emission tomography (PET).Methods:Substrate depletion assays using rat liver microsomes (RLM) were performed for three analogouscompounds which differ with regard to the metabolically vulnerable substituent at the xanthine C8 position.Incubation conditionswerevariedsystematically. Additionally, the stability of the cofactor NADPH duringing cubation was investigated.Results:Microsomal metabolism was strongly influenced by buffer pH, organic solvents and preincubation time.Substrate depletion values varied up to5-fold depending on incubation matrix composition, however, the rankorder of metabolic stability remained unchanged. Prolonged incubation periods led to drastic loss in enzymeactivity which could not be prevented by addition of metal chelators or antioxidants. Cofactor NADPH wasrapidlyoxidizedinmicrosomalmatrix,evenintheabsenceofcytochromeP450substrates.Discussion:Insummary,short incubation times, precise pH control and minimal concentrations of organic solvents are mandatory to obtain reliable microsomal stability data. Furthermore, invitro metabolic stability of thetested A 1 AR ligands varied largely depending on the particular C8 substituent. Consequently, structural modifications at the xanthine C8 position appear to be a promising strategy for the improvement of A1AR PETradioligands
000859684 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000859684 588__ $$aDataset connected to CrossRef
000859684 7001_ $$0P:(DE-Juel1)131810$$aBier, Dirk$$b1$$ufzj
000859684 7001_ $$0P:(DE-Juel1)140200$$aBauer, Andreas$$b2$$ufzj
000859684 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b3
000859684 7001_ $$0P:(DE-Juel1)131824$$aHolschbach, Marcus$$b4$$ufzj
000859684 773__ $$0PERI:(DE-600)1491825-0$$a10.1016/j.vascn.2018.11.005$$gVol. 95, p. 16 - 26$$p16 - 26$$tJournal of pharmacological & toxicological methods$$v95$$x1056-8719$$y2019
000859684 8564_ $$uhttps://juser.fz-juelich.de/record/859684/files/1-s2.0-S1056871918307135-main.pdf$$yRestricted
000859684 8564_ $$uhttps://juser.fz-juelich.de/record/859684/files/1-s2.0-S1056871918307135-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000859684 909CO $$ooai:juser.fz-juelich.de:859684$$pVDB
000859684 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156407$$aForschungszentrum Jülich$$b0$$kFZJ
000859684 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131810$$aForschungszentrum Jülich$$b1$$kFZJ
000859684 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)140200$$aForschungszentrum Jülich$$b2$$kFZJ
000859684 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b3$$kFZJ
000859684 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131824$$aForschungszentrum Jülich$$b4$$kFZJ
000859684 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000859684 9141_ $$y2019
000859684 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000859684 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ PHARMACOL TOX MET : 2017
000859684 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000859684 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000859684 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000859684 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000859684 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000859684 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000859684 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000859684 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000859684 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000859684 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000859684 920__ $$lyes
000859684 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000859684 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x1
000859684 980__ $$ajournal
000859684 980__ $$aVDB
000859684 980__ $$aI:(DE-Juel1)INM-5-20090406
000859684 980__ $$aI:(DE-Juel1)INM-2-20090406
000859684 980__ $$aUNRESTRICTED